Dario A. Paggiarino, Chief Medical Officer at EyePoint Pharmaceuticals, Inc. (EYPT), sold 30,625 shares at $22.00 ($674K) on 2023-12-04, disclosed to the SEC on 2023-12-06.
Scheduled sale ($674k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EYPT | SELL | 2024-01-25 | $551K | — | Filing → |
| EYPT | SELL | 2024-01-10 | $968K | — | Filing → |
| EYPT | SELL | 2023-12-15 | $29K | — | Filing → |